Please login to the form below

aspirin

This page shows the latest aspirin news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in diabetic heart disease

The study showed that in diabetics with CAD and no prior history of heart attack or stroke, Brilinta given on top of aspirin therapy achieved a statistically-significant reduction in a ... Last year, the GLOBAL LEADERS study last year also showed that

Latest news

Xarelto no better than aspirin in secondary stroke study

low-dose aspirin, which is commonly prescribed for this purpose, but failed to hit the mark at the interim stage. ... While bleeding rates were low overall, an increase in bleeding was observed in the rivaroxaban arm compared to the low dose aspirin arm,
Xarelto beats aspirin for recurrent blood clots

A new phase III trial shows that Bayer and Janssen's novel oral anticoagulant (NOAC) Xarelto is more effective than aspirin at preventing recurrent blood clots, with no increase in bleeding ... It's already known that after an initial few months of
MHRA launches medicines side effects awareness drive

The MHRA credits such reports for action including no longer prescribing aspirin to children, which resulted in the virtual elimination of Reye's syndrome cases in many EU countries.
NICE backs expanded use of Brilique in final guidance

Currently delivered at a 90mg dose with aspirin for 12 months after a heart attack, the oral drug could now be taken twice daily with aspirin at a 60mg dose for ... The new Final Appraisal Determination comes on the back of the PEGASUS study, which
NICE backs use of AZ's Brilique as maintenance therapy

AstraZeneca's antiplatelet drug Brilique can be used alongside aspirin as a long-term maintenance therapy in patients who have had a heart attack, according to NICE. . ... The value of longer-term use in heart attack patients was revealed in the PEGASUS

More from news
Approximately 1 fully matching, plus 68 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

Zontivity is a protease-activated receptor-1 antagonist indicated for use in combination with daily aspirin and/or clopidogrel to reduce thrombotic cardiovascular events.
Using social data to see patients more clearly

Drugs and databases analysed. The study focused on two drugs, aspirin and Lipitor, that had a relatively high prevalence among the ADR reports in both the clinical and the social media ... To begin with, the two most common reactions to aspirin in both
Lonafarnib: promising results in first-ever trial for progeria

Low-dose aspirin is often used for prevention of heart attacks and children have received heart bypass surgery.
Country report: The healthcare market in Germany

Pharmaceutical market. With a tradition of invention in the medical field that brought aspirin, Germany has been an attractive pharmaceutical market for years.
Country report: The healthcare market in Japan

Under the revised Pharmaceutical Affairs Act, supermarkets and other stores can sell non-prescription drugs, including cold tablets and aspirin.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

Natasha Giordano joins PLx Pharma

We are confident Natasha will be a driving force for PLx as we transition from the development phase to the commercial launch of our lead product, PL2200 Aspirin.”. ... I look forward to building on the compelling clinical data and initial market

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Modern alternatives to banner exhibition stands (why a reusable pharma exhibition stand could save you money)

Consider things like tasty food, care packages for attendees who are on their feet all day (include power-snacks, blister plasters and aspirin!).
Pharma exhibition stand design: size doesn’t have to matter

Consider things like tasty food, care packages for attendees who are on their feet all day (include power-snacks, blister plasters and aspirin!) or a handy phone charger to stand out
Introduction to the manufacturing of biologics

There is a significant distinction that needs to be made between traditional small molecule pharmaceuticals (such as aspirin), and biopharmaceuticals.
Are we harnessing the full emotional power of brand creativity?

In their 1981 experiment, psychologists Branthwaite and Cooper concluded that branded aspirin tablets were “significantly more effective than unbranded tablets in relieving headaches” accounting for some “one-quarter to one-third”

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director – UK Office: Excellent salary and benefits

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Strategic Planner, Healthcare Advertising Agency: Salary TBC

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director, Healthcare Communications: Salary TBC

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Subscribe to our email news alerts

PMHub

Add my company

JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...